Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rafael Dal-Ré

Showing results (41-50 of 79) with videos related to

Pageof 8
Sort By:
The Lancet. Infectious Diseases|April 1, 2022
Availability of oral antivirals against SARS-CoV-2 infection and the requirement for an ethical prescribing approachRafael Dal-Ré, Sören L Becker, Emmanuel Bottieau, et al.
European Journal of Human Genetics : EJHG|January 17, 2013
Informed consent for whole-genome sequencing studies in the clinical setting. Proposed recommendations on essential content and processCarmen Ayuso, José M Millán, Marta Mancheño, et al.
Anales De Pediatria|June 6, 2020
[Participant-funded clinical trials on rare diseases]Rafael Dal-Ré, Francesc Palau, Encarna Guillén-Navarro, et al.
British Journal of Clinical Pharmacology|April 19, 2017
Public preferences on written informed consent for low-risk pragmatic clinical trials in SpainRafael Dal-Ré, Antonio J Carcas, Xavier Carné, et al.
BMC Medical Research Methodology|September 20, 2017
Patients' beliefs regarding informed consent for low-risk pragmatic trialsRafael Dal-Ré, Antonio J Carcas, Xavier Carné, et al.
Journal of Alzheimer'S Disease : JAD|November 29, 2012
Clinical observational research on Alzheimer's disease: what clinical trial registries can tellRafael Dal-Ré, Karine Fauria, Nina Gramunt, et al.
Anales De Pediatria|June 7, 2021
Participant-funded clinical trials on rare diseasesRafael Dal-Ré, Francesc Palau, Encarna Guillén-Navarro, et al.
Journal of Clinical Epidemiology|November 12, 2021
European non-commercial sponsors showed substantial variation in results reporting to the EU trial registryRafael Dal-Ré, Ben Goldacre, Ignacio Mahillo-Fernández, et al.
Travel Medicine and Infectious Disease|April 7, 2022
High heterogeneity on the accepted vaccines for COVID-19 certificates in European countriesRafael Dal-Ré, Rita Banzi, Sören L Becker, et al.
Journal of Clinical Microbiology|January 5, 2002
Importance of local variations in antibiotic consumption and geographical differences of erythromycin and penicillin resistance in Streptococcus pneumoniaeCésar García-Rey, Lorenzo Aguilar, Fernando Baquero, et al.
Pageof 8

Showing results (41-50 of 79) with videos related to

Sort By:
Pageof 8
The Lancet. Infectious Diseases|April 1, 2022
Availability of oral antivirals against SARS-CoV-2 infection and the requirement for an ethical prescribing approachRafael Dal-Ré, Sören L Becker, Emmanuel Bottieau, et al.
European Journal of Human Genetics : EJHG|January 17, 2013
Informed consent for whole-genome sequencing studies in the clinical setting. Proposed recommendations on essential content and processCarmen Ayuso, José M Millán, Marta Mancheño, et al.
Anales De Pediatria|June 6, 2020
[Participant-funded clinical trials on rare diseases]Rafael Dal-Ré, Francesc Palau, Encarna Guillén-Navarro, et al.
British Journal of Clinical Pharmacology|April 19, 2017
Public preferences on written informed consent for low-risk pragmatic clinical trials in SpainRafael Dal-Ré, Antonio J Carcas, Xavier Carné, et al.
BMC Medical Research Methodology|September 20, 2017
Patients' beliefs regarding informed consent for low-risk pragmatic trialsRafael Dal-Ré, Antonio J Carcas, Xavier Carné, et al.
Journal of Alzheimer'S Disease : JAD|November 29, 2012
Clinical observational research on Alzheimer's disease: what clinical trial registries can tellRafael Dal-Ré, Karine Fauria, Nina Gramunt, et al.
Anales De Pediatria|June 7, 2021
Participant-funded clinical trials on rare diseasesRafael Dal-Ré, Francesc Palau, Encarna Guillén-Navarro, et al.
Journal of Clinical Epidemiology|November 12, 2021
European non-commercial sponsors showed substantial variation in results reporting to the EU trial registryRafael Dal-Ré, Ben Goldacre, Ignacio Mahillo-Fernández, et al.
Travel Medicine and Infectious Disease|April 7, 2022
High heterogeneity on the accepted vaccines for COVID-19 certificates in European countriesRafael Dal-Ré, Rita Banzi, Sören L Becker, et al.
Journal of Clinical Microbiology|January 5, 2002
Importance of local variations in antibiotic consumption and geographical differences of erythromycin and penicillin resistance in Streptococcus pneumoniaeCésar García-Rey, Lorenzo Aguilar, Fernando Baquero, et al.
Pageof 8